Fresh Rounds

Kylix Bio, Inc. funding

Kylix Bio, Inc., a biotechnology company based in Dover, DE (founded 2025), filed a Form D with the SEC on January 26, 2026 and reported $850K raised of a $12M offering.

Amount raised$850K
Offering size$12M
Filed with the SECJanuary 26, 2026
First saleJanuary 15, 2026
IndustryBiotechnology
SecuritiesOptions or warrants
LocationDover, DE
Founded2025
Entity typeCorporation
Investors so far5
Minimum investment$50K
Revenue rangeDecline to Disclose

Other health care rounds in Delaware